These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 6111982

  • 1. Pharmacology of GYKI-41 099 (chlorpropanol, Tobanum) a new potent beta-adrenergic antagonist.
    Fekete MI, Elekes I, Kürti M, Borvendég J.
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):190-202. PubMed ID: 6111982
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
    Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H.
    Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
    [Abstract] [Full Text] [Related]

  • 3. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO, Fiehring H, Oltmanns G, Femmer K.
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract] [Full Text] [Related]

  • 4. Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.
    Nakayama K, Oshima T, Koike H.
    Jpn J Pharmacol; 1979 Dec; 29(6):935-45. PubMed ID: 44326
    [Abstract] [Full Text] [Related]

  • 5. [Atenolol, its cardioselective property for adrenergic beta-receptor blocking action and effect on the cardiac function (author's transl)].
    Kanno M, Nakaya H, Hattori Y, Izumi T, Nishimura T, Sakai K, Abiko Y.
    Nihon Yakurigaku Zasshi; 1980 Oct; 76(7):621-32. PubMed ID: 6111522
    [Abstract] [Full Text] [Related]

  • 6. Cardiovascular and antiarrhythmic effects of 1-(4,5-dichloro-2-thienyl)-2-t-butylaminoethanol (QM-5119), a new beta-adrenergic blocking agent.
    Darias V, del Río J.
    Arzneimittelforschung; 1974 Nov; 24(11):1756-9. PubMed ID: 4155633
    [No Abstract] [Full Text] [Related]

  • 7. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR, Vyas DS.
    Indian J Physiol Pharmacol; 1973 Nov; 17(3):227-34. PubMed ID: 4151008
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z, Robak J, Kostka-Trabka E, Grodzińska L, Górka Z, Gryglewski R.
    Folia Biol (Krakow); 1974 Nov; 22(2):217-28. PubMed ID: 4151603
    [No Abstract] [Full Text] [Related]

  • 9. Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.
    Hicks PE, Cavero I, Manoury P, Lefevre-Borg F, Langer SZ.
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1025-34. PubMed ID: 2888869
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
    Varró A, Rabloczky G, Jaszlits L, Kürthy M, Zubovics Z, Toldy L.
    Drugs Exp Clin Res; 1987 Sep; 13(1):21-8. PubMed ID: 3595441
    [Abstract] [Full Text] [Related]

  • 11. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA, Robson RD, Share NN.
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [Abstract] [Full Text] [Related]

  • 12. Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
    Hastings SG, Smith RD, Corey RM, Essenburg AD, Pettway CE, Tessman DK.
    Arch Int Pharmacodyn Ther; 1977 Mar; 226(1):81-99. PubMed ID: 17372
    [No Abstract] [Full Text] [Related]

  • 13. A new type of cardioselective adrenoceptive blocking drug.
    Barrett AM, Carter J, Fitzgerald JD, Hull R, Le Count D.
    Br J Pharmacol; 1973 Jun; 48(2):340P. PubMed ID: 4147428
    [No Abstract] [Full Text] [Related]

  • 14. [On the pharmacology of the beta-receptor blocker penbutolol (author's transl)].
    Kaiser J, Härtfelder G, Lindner E, Schölkens B.
    Arzneimittelforschung; 1980 Jun; 30(3):420-7. PubMed ID: 6992788
    [Abstract] [Full Text] [Related]

  • 15. A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.
    Brittain RT, Levy GP.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):681-4. PubMed ID: 10948
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings].
    Boudot JP, Cavero I, Fénard S, Lefèvre-Borg F, Manoury P, Roach AG.
    Br J Pharmacol; 1979 Jul; 66(3):445P. PubMed ID: 43176
    [No Abstract] [Full Text] [Related]

  • 20. Adrenoceptor blocking effects of arotinolol, a new combined alpha- and beta-adrenoceptor blocking agent.
    Miyagishi A, Nakahara H, Hara Y.
    Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):249-62. PubMed ID: 6210068
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.